4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-089023
Options or other derivatives
- Chief Executive Officer acquired 460,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 1 in the form Stock Option (right to buy) | +460,000 | 460,000 | D |
Loading xslF345X05/ownership.xml…